iStent infinite trabecular micro-bypass system model iS3: Clinical Trials

1 trial of iStent infinite trabecular micro-bypass system model iS3, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Recruiting 1

Follow iStent infinite trabecular micro-bypass system model iS3: new trials by email Literature Review of iStent infinite trabecular micro-bypass system model iS3 trials Research Report on iStent infinite trabecular micro-bypass system model iS3

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucoma
iStent infinite trabecular micro-bypass system model iS3, iDose TR (Travoprost intracameral Implant) 75mcg - Open Angle Glaucoma, Pigmentary Glaucoma
Phase 4RecruitingJonathon Myers202026-01-052025-11-14

Conditions studied

Exfoliation Syndrome (1)  ·  Glaucoma, Open-Angle (1)

Sponsors

Jonathon Myers (1)

Countries

United States (1)

Top investigators

Dilru Amarasekera, MD (1)